Publikationen, an denen er mitarbeitet I. Robles Fernández (13)

2022

  1. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10

2021

  1. Identification of mirnas as viable aggressiveness biomarkers for prostate cancer

    Biomedicines, Vol. 9, Núm. 6

2020

  1. Liquid biopsy and prostate cancer. Current evidence applied to clinical practice

    Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 139-147

2019

  1. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

    Breast Cancer Research, Vol. 21, Núm. 1

  2. The role of miRNAs as biomarkers in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 165-174

2018

  1. Genetic markers a landscape in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 775, pp. 1-10

  2. Improving the genetic signature of prostate cancer, the somatic mutations

    Urologic Oncology: Seminars and Original Investigations, Vol. 36, Núm. 6, pp. 312.e17-312.e23

  3. The influence of nutritional factors on prostate cancer incidence and aggressiveness

    Aging Male, Vol. 21, Núm. 1, pp. 31-39

2017

  1. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs

    Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482

  2. Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness

    PLoS ONE, Vol. 12, Núm. 10

  3. Circulating tumor cells: Markers and methodologies for enrichment and detection

    Methods in Molecular Biology (Humana Press Inc.), pp. 283-303

  4. Significance of EGFR expression in circulating tumor cells

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 285-296

  5. Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine

    Molecular Diagnosis and Therapy, Vol. 21, Núm. 2, pp. 167-178